Highlight Edition
September 9, 2020
Highlighted Stories
AstraZeneca Shares Plunge As COVID Vaccine Study Put On Hold Due To “Adverse Reaction”
NSAIDs, Such As Ibuprofen, Not Associated With Any Adverse Effects in People With C19
Contact Tracing Apps Unlikely to Contain C19 Spread: No Real-World Evidence of Effectiveness
Vitamin D Deficiency May Raise Risk of Getting C19
Small Neutralizing Antibody Identified That May Prevent C19 Infection
Genetics Could Impact C19 Treatments
Fast, Portable C19 Test Could Bypass the Lab
LabCorp to launch single home swab test for C19, the flu & RSV
Buyer Beware on C19 Home Testing Kits
C19 Patients Suffer Long-Term Lung and Heart Damage – But They Can Recover With Time
C19-damaged lungs can repair themselves in three months
Asymptomatic children with C19 could develop heart problems
Kids Can’t Go to School. Should They Play Youth Sports?
Classroom Air Quality Poses Hurdle to Reopening Schools
Sweden Close To Victory Over Coronavirus; Never Had A Lockdown Or Mask Mandate
Herd Immunity To C19 May Have Been Reached In NY, CA, Scientist Claims
SD governor criticizes study suggesting Sturgis bike rally led to 260,000 C19 cases
Hydroxychloroquine Reduces Risk Of Death From COVID-19 By 30%, Latest Italian Study Shows For a review of 94 HCQ studies (including 56 peer reviewed), see https://c19study.com/